Back to Search
Start Over
Asystole-induced Bradycardia by Dexmedetomidine during Endoscopic Submucosal Dissection.
- Source :
-
Internal medicine (Tokyo, Japan) [Intern Med] 2022 Aug 15; Vol. 61 (16), pp. 2457-2461. Date of Electronic Publication: 2022 Feb 01. - Publication Year :
- 2022
-
Abstract
- Although dexmedetomidine (DEX) is a widely used analgesic and sedative agent for endoscopic procedures, cardiovascular complications, such as bradycardia and hypotension, are frequently experienced. We herein report the first case of asystole-induced bradycardia due to DEX during endoscopic submucosal dissection (ESD). An 81-year-old man without cardiovascular diseases was referred for gastric carcinoma. ESD was started after administering a loading dose of DEX followed by a continuous maintenance infusion of DEX. The patient's heart rate gradually decreased, and then cardiac arrest occurred. DEX has a risk of cardiac arrest, so bradycardia should not be underestimated during sedation with DEX.
Details
- Language :
- English
- ISSN :
- 1349-7235
- Volume :
- 61
- Issue :
- 16
- Database :
- MEDLINE
- Journal :
- Internal medicine (Tokyo, Japan)
- Publication Type :
- Academic Journal
- Accession number :
- 35110487
- Full Text :
- https://doi.org/10.2169/internalmedicine.8813-21